Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock ...

"If revenues decline in 2025 cash burn increases, the balance sheet will look far more vulnerable, and shares could trade below $10 if the data holds up." Shares of 10x Genomics (TXG) rose 4.6% on ...

Shares of 10x Genomics and Illumina are down some 40% this year. Sales of their research equipment have been hurt by ...

the initiative is now benefiting from new partnerships with 10x Genomics and Ultima Genomics, industry leaders in advanced tools that make collecting single cell data faster, more scalable ...

Nearly 100 workers at a Tri-Valley-based biosciences company are in their final weeks on the job this month as 10x Genomics ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

It's been a good week for 10x ... this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic 10x Genomics analyst ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other genomics ...

Gene sequencing technology company 10x Genomics (NASDAQ ... and according to data compiled by S&P Global Market Intelligence its price was down by more than 9% week to date as of early Friday ...

That occurred on Monday, when Tejas Savant from white-shoe investment bank Morgan Stanley reduced his 10x Genomics price target to $18 per share, far down from his previous level of $26.